Secondary analysis of 2200 HeartMate 3 LVAD recipients in the MOMENTUM 3 trials: early right ventricular failure (18.3%) was associated with lower 2-year survival (62.0% vs 84.6%) and higher adjusted mortality (aHR 3.3); RVAD need had worst outcomes.
Secondary analysisn = 2,200
Sayer et al. Early right ventricular failure following HeartMate 3 left ventricular assist device implantation: Risk factors and outcomes